The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Edgewise Therapeutics Inc shares valued at $25,520 were sold by Russell Alan J on May 02 ’25. At $16.45 per share, Russell Alan J sold 1,551 shares. The insider’s holdings dropped to 18,521 shares worth approximately $0.27 million following the completion of this transaction.
Also, MOORE JOHN R sold 1,930 shares, netting a total of over 31,757 in proceeds. Following the sale of shares at $16.45 each, the insider now holds 6,531 shares.
Before that, KOCH KEVIN had sold 4,276 shares from its account. In a trade valued at $70,358, the President and CEO traded Edgewise Therapeutics Inc shares for $16.45 each. Upon closing the transaction, the insider’s holdings decreased to 4,276 shares, worth approximately $0.3 million.
As published in their initiating research note from Guggenheim on April 30, 2025, Edgewise Therapeutics Inc [EWTX] has been a Buy and the price target has been revised to $41. Analysts at Scotiabank downgraded the stock from ‘”a Sector outperform”‘ to ‘”a Sector perform”‘ outlook in a report released in early April. As of March 07, 2025, Scotiabank has initiated its “Sector outperform” rating for EWTX. Earlier on January 22, 2025, Stifel initiated its rating. Their recommendation was “a Hold” for EWTX stock.
Analyzing EWTX Stock Performance
On last trading session,, Edgewise Therapeutics Inc [NASDAQ: EWTX] plunged -0.14% to $14.47. The stock’s lowest price that day was $14.35, but it reached a high of $14.81 in the same session. During the last five days, there has been a drop of approximately -8.13%. Over the course of the year, Edgewise Therapeutics Inc shares have dropped approximately -45.81%. Shares of the company reached a 52-week high of $30.48 on 02/06/25 and a 52-week low of $10.60 on 04/07/25.
Support And Resistance Levels for Edgewise Therapeutics Inc (EWTX)
According to the 24-hour chart, there is a support level at 14.28, which, if violated, would cause prices to drop to 14.08. In the upper region, resistance lies at 14.74. The next price resistance is at 15.00. RSI (Relative Strength Index) is 43.66 on the 14-day chart, showing neutral technical sentiment.
Is Edgewise Therapeutics Inc subject to short interest?
Stocks of Edgewise Therapeutics Inc saw a sharp rise in short interest on 2025-05-30 jumping by 1.05 million shares to 14.31 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 13.26 million shares. A jump of 7.33% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 13.14 of the overall float, the days-to-cover ratio (short ratio) jumped to 13.14.
Which companies own the most shares of Edgewise Therapeutics Inc (EWTX)?
In terms of Edgewise Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 50 in the next 12 months, up nearly 245.07% from the previous closing price of $14.49. Analysts anticipate Edgewise Therapeutics Inc stock to reach 50 by 2025, with the lowest price target being 50. In spite of this, 1 analysts ranked Edgewise Therapeutics Inc stock as Buy at the end of 2025. On November 22, 2024, Evercore ISI assigned a price target of “an Outperform” to the stock and initiated coverage with a $45.
